| GC12493-1mg |
|
120882-22-6 |
|
0 |
C14H15N5O5S3 |
|
|
|
| GC12491-10mg |
|
29477-83-6 |
|
0 |
C14H13NO7 |
|
|
|
| GC12491-5mg |
|
29477-83-6 |
|
0 |
C14H13NO7 |
|
|
|
| GC12491-1mg |
|
29477-83-6 |
|
0 |
C14H13NO7 |
|
|
|
| GC12490-50mg |
|
137730-52-0 |
|
0 |
C20H23N.C4H4O4 |
|
|
|
| GC12490-10mg |
|
137730-52-0 |
|
0 |
C20H23N.C4H4O4 |
|
|
|
| GC12489-100mg |
|
1134822-09-5 |
Ivacaftor benzenesulfonate
|
0 |
C30H34N2O6S |
|
|
|
| GC12489-5mg |
|
1134822-09-5 |
Ivacaftor benzenesulfonate
|
0 |
C30H34N2O6S |
|
|
|
| GC12488-50mg |
|
138199-51-6 |
(RS)-(Tetrazol-5-yl)glycine
|
0 |
C3H5N5O2 |
|
|
|
| GC12488-10mg |
|
138199-51-6 |
(RS)-(Tetrazol-5-yl)glycine
|
0 |
C3H5N5O2 |
|
|
|
| GC12487-50mg |
|
385786-48-1 |
|
0 |
C21H16ClN3O2 |
|
|
|
| GC12487-10mg |
|
385786-48-1 |
|
0 |
C21H16ClN3O2 |
|
|
|
| GC12487-5mg |
|
385786-48-1 |
|
0 |
C21H16ClN3O2 |
|
|
|
| GC12486-10mM (in 1mL DMSO) |
|
1195768-06-9 |
Dabrafenib Mesylate (GSK-2118436)
|
0 |
C24H24F3N5O5S3 |
|
|
|
| GC12486-100mg |
|
1195768-06-9 |
Dabrafenib Mesylate (GSK-2118436)
|
0 |
C24H24F3N5O5S3 |
|
|
|
| GC12486-50mg |
|
1195768-06-9 |
Dabrafenib Mesylate (GSK-2118436)
|
0 |
C24H24F3N5O5S3 |
|
|
|
| GC12486-10mg |
|
1195768-06-9 |
Dabrafenib Mesylate (GSK-2118436)
|
0 |
C24H24F3N5O5S3 |
|
|
|
| GC12485-50mg |
|
298690-60-5 |
|
0 |
C17H18FNO2S |
|
|
|
| GC12485-10mg |
|
298690-60-5 |
|
0 |
C17H18FNO2S |
|
|
|
| GC12484-100mg |
|
1440209-96-0 |
|
0 |
C16H16N2O3 |
|
|
|
